Evidence map›Paper›PMID 33451165›Full record

ArticleHealthcare (Basel, Switzerland)2021

Analyzing the Impact of Vaccine Availability on Alternative Supplier Selection Amid the COVID-19 Pandemic: A cFGM-FTOPSIS-FWI Approach.

Toly Chen, Yu-Cheng Wang, Hsin-Chieh Wu

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Toly ChenDepartment of Industrial Engineering and Management, National Chiao Tung University, University Road, Hsinchu 1001, Taiwan.
Yu-Cheng WangDepartment of Aeronautical Engineering, Chaoyang University of Technology, Taichung 41349, Taiwan.ORCID 0000-0003-4339-1665
Hsin-Chieh WuDepartment of Industrial Engineering and Management, Chaoyang University of Technology, Taichung 41349, Taiwan.ORCID 0000-0002-3663-6284
Chaoyang University of Technology · TWNational Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The supply chain disruption caused by the coronavirus disease 2019 (COVID-19) pandemic has forced many manufacturers to look for alternative suppliers. How to choose a suitable alternative supplier in the COVID-19 pandemic has become an important task. To fulfill this task, this research proposes a calibrated fuzzy geometric mean (cFGM)-fuzzy technique for order preference by similarity to ideal solution (FTOPSIS)-fuzzy weighted intersection (FWI) approach. In the proposed methodology, first, the cFGM method is proposed to accurately derive the priorities of criteria. Subsequently, each expert applies the FTOPSIS method to compare the overall performances of alternative suppliers in the COVID-19 pandemic. The sensitivity of an expert to any change in the overall performance of the alternative supplier is also considered. Finally, the FWI operator is used to aggregate the comparison results by all experts, for which an expert's authority level is set to a value proportional to the consistency of his/her pairwise comparison results. The cFGM-FTOPSIS-FWI approach has been applied to select suitable alternative suppliers for a Taiwanese foundry in the COVID-19 pandemic.

Indexed as

alternative supplierCOVID-19 pandemicfuzzy collaborative intelligencewafer fabrication

Identifiers

PMID33451165
PMCPMC7828742
OpenAlexW3119596232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.